← Eichor
Study identifier: NCT06619912 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

Condition: Postoperative Delirium · Preoperative Sleep Disorder  ·  Sponsor: Xijing Hospital

PhasePhase 3
Planned participants686
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Delirium is a common consequence of cardiac surgery and associates with poor outcomes. Multiple causes can trigger delirium occurence, and it has been hypothesised that sleep disturbances can be one of them. Dexmedetomidine may be effective in reducing delirium. The aim of this study was to demonstrate preoperative dexmedetomidine nasal spray in cardiac surgery patients can reduce postoperative delirium by improving preoperative sleep.

This description comes directly from the study's public registry record.

Talk to the study team

Chong Lei, M.D., phd  ·  86-18629011362  ·  crystalleichong@126.com

Zefei Zhang, M.D.  ·  86-18811797795  ·  zzfanita7@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xijing HospitalXi'an, Shaanxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06619912